PLI Scheme for Pharmaceuticals — Up to ₹10,000 Cr in Incentives — Eligibility Criteria
PLI Scheme for Pharmaceuticals — Up to ₹10,000 Cr in Incentives is open to revenue · profit-stage startups registered in India. The full eligibility criteria — qualifying sectors, states and entity types — are below.
Who can apply
A few conditions apply to every applicant, and a set of financial thresholds then decides which group you are placed in.
Conditions that apply to everyone
- You must be a pharmaceutical goods manufacturer registered in India.
- You must be manufacturing products covered by the scheme's three defined product categories.
- You cannot claim an incentive for the same product under another PLI scheme.
Group thresholds, based on Global Manufacturing Revenue in FY 2019-20
- Group A: global manufacturing revenue of pharmaceutical goods or in-vitro diagnostic medical devices of ₹5,000 crore or more; minimum cumulative investment of ₹1,000 crore over 5 years; minimum eligible product turnover of ₹50 crore in FY 2022-23.
- Group B: global manufacturing revenue between ₹500 crore and ₹5,000 crore; minimum cumulative investment of ₹250 crore over 5 years; minimum eligible product turnover of ₹10 crore in FY 2022-23.
- Group C: global manufacturing revenue below ₹500 crore; minimum cumulative investment of ₹50 crore over 5 years; minimum eligible product turnover of ₹1 crore in FY 2022-23.
- Group C (MSME): you must fall within the Micro, Small and Medium Enterprises category and sit in Group C, commit eligible investment over 5 years, and reach a minimum eligible product turnover of ₹50 lakh in FY 2022-23.
Staying eligible year after year From FY 2023-24 onwards, applicants need to show at least 7% growth in sales over the previous financial year to keep claiming incentives.
PLI Scheme for Pharmaceuticals — Up to ₹10,000 Cr in Incentives is open to startups at the revenue and profitable stage working in health lifesciences. It is open to startups registered anywhere in India. Applicants should be registered as private limited, llp and opc.
- Eligible stage
- Revenue · Profit
- Location
- Open to startups registered in India
- Entity type
- Private Limited, Llp, Opc, Partnership, Proprietorship
← Back to PLI Scheme for Pharmaceuticals — Up to ₹10,000 Cr in Incentives overview